Evidence map›Paper›PMID 24166581›Full record

ArticleJournal of neuro-oncology2014

Gross total resection improves overall survival in children with choroid plexus carcinoma.

Matthew Z Sun, Michael E Ivan, Aaron J Clark, Michael C Oh, Arthur R Delance, Taemin Oh, Michael Safaee, Gurvinder Kaur, Orin Bloch, Annette Molinaro and 2 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Successful multimodal treatment of a gigantic choroid plexus carcinoma (CPC) in an 8-year-old girl.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Matthew Z SunDepartment of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave., San Francisco, CA, 94117, USA.
Michael E Ivan
Aaron J Clark
Michael C Oh
Arthur R Delance
Taemin Oh
Michael Safaee
Gurvinder Kaur
Orin Bloch
Annette Molinaro
Nalin Gupta
Andrew T Parsa
Neurological Surgery · USUniversity of California, San Francisco · USNorthwestern University · US

Funding

Complement activation promotes CD133+ glioma cell proliferationF32NS073326 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI OH, MICHAEL C · 2011 to 2011
$57k
Howard Hughes Medical InstituteNINDS NIH HHS F32NS073326-01
6 · The paper itself

Abstract

Choroid plexus carcinoma (CPC) is a rare, malignant, primary brain tumor with a poor prognosis. While previous reports have shown benefits of aggressive surgery, very few large-scale studies have focused exclusively on the pediatric population, for whom the risks of aggressive surgery must be weighed carefully against the benefits. We performed a comprehensive systematic review of pediatric CPCs to test the effects of gross total resection (GTR) on overall survival (OS) and progression-free survival (PFS). A Pubmed search was performed to identify children with CPC who underwent surgical resection. Only disaggregated clinical cases in which extent of resection was confirmed by CT or MRI were included for analysis. Kaplan-Meier and multivariate Cox regression survival analyses were performed to determine the effects of extent of resection on OS and PFS. Disaggregated clinical data from a total of 102 pediatric CPC patients (age ≤18 years) with known extent of resection and overall survival were analyzed. GTR was significantly associated with better OS by Kaplan-Meier analysis (logrank p < 0.001). Multivariate Cox regression analysis adjusting for age, gender, tumor location (supratentorial vs. infratentorial), and type of adjuvant therapy (chemotherapy, radiation, and combined therapy), showed that GTR independently increased OS (p = 0.006). While GTR also improved PFS on Kaplan-Meier analysis (p = 0.027), the effect did not meet our criteria for significance in our multivariate Cox model (p = 0.120). GTR improved OS of pediatric CPC and is recommended if it can be safely performed.

Indexed as

Brain NeoplasmsCarcinomaChildChild, PreschoolChoroid Plexus NeoplasmsFemaleHumansKaplan-Meier EstimateMagnetic Resonance ImagingMaleNeurosurgical ProceduresProportional Hazards ModelsTomography, X-Ray ComputedTreatment Outcome

Identifiers

PMID24166581
OpenAlexW2052209235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.